High-density lipoprotein deficiency in genetically modified mice deeply affects skin morphology: A structural and ultrastructural study

Experimental Cell Research

Volumn 338, Issue 1, 2015, Pages 105-112

  Arnaboldi, Francesca ^a   Busnelli, Marco ^b   Cornaghi, Laura ^a   Manzini, Stefano ^b   Parolini, Cinzia ^b   Dellera, Federica ^b   Ganzetti, Giulia Sara ^b   Sirtori, Cesare Riccardo ^b   Donetti, Elena ^a   Chiesa, Giulia ^b  

^a Department of Biomedical Sciences for Health   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Apolipoproteins; Cholesterol clefts; HDLs; Transmission electron microscopy

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FOAM CELL; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPID STORAGE; MICROSCOPY; MOUSE; NONHUMAN; POST HOC ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN BIOPSY; SKIN STRUCTURE; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; C57BL MOUSE; GENETICS; HYPOALPHALIPOPROTEINEMIA; PATHOLOGY; SKIN; XANTHOMATOSIS;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; HYPOALPHALIPOPROTEINEMIAS; MICE, INBRED C57BL; MICE, KNOCKOUT; SKIN; XANTHOMATOSIS;

EID: 84942193193     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.07.032     Document Type: Article

References (34)

1. Kendall A.C., Pilkington S.M., Massey K.A., Sassano G., Rhodes L.E., Nicolaou A. Distribution of bioactive lipid mediators in human skin. J. Investig. Dermatol. 2015, 10.1038/jid.2015.41.
2. Visscher M., Narendran V. The ontogeny of skin. Adv. Wound Care 2014, 3:291-303. 10.1089/wound.2013.0467.
3. Chapkin R.S., Ziboh V.A., Marcelo C.L., Voorhees J.J. Metabolism of essential fatty acids by human epidermal enzyme preparations: evidence of chain elongation. J. Lipid Res. 1986, 27:945-954.
4. Feingold K.R., Elias P.M. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim. Biophys. Acta 2014, 1841:280-294. 10.1016/j.bbalip.2013.11.007.
5. te Pas M.F., Lombardi P., Havekes L.M., Boonstra J., Ponec M. Regulation of low-density lipoprotein receptor expression during keratinocyte differentiation. J. Investig. Dermatol. 1991, 97:334-339.
6. Tsuruoka H., Khovidhunkit W., Brown B.E., Joachim W.F., Peter M.E., Kenneth R.F. Scavenger receptor class B type I is expressed in cultured keratinocytes and epidermis. Regulation in response to changes in cholesterol homeostasis and barrier requirements. J. Biol. Chem. 2002, 277:2919-2922. 10.1074/jbc.M106445200.
7. Jiang Y.J., Lu B., Kim P. Regulation of ABCA1 expression in human keratinocytes and murine epidermis. J. Lipid Res. 2006, 47:2248-2258. 10.1194/jlr.M600163-JLR200.
8. Jiang Y.J., Lu B., Tarling E.J., Kim P., Man M.Q., Crumrine D., Edwards P.A., Elias P.M., Feingold K.R. Regulation of ABCG1 expression in human keratinocytes and murine epidermis. J. Lipid Res. 2010, 51:3185-3195. 10.1194/jlr.M006445.
9. Barra R.M., Fenjves E.S., Taichman L.B. Secretion of apolipoprotein E by basal cells in cultures of epidermal keratinocytes. J. Investig. Dermatol. 1994, 102:31-66.
10. Fu L., Matsuyama I., Chiba T., Korenaga T., Guo Z., Fu X., et al. Extrahepatic expression of apolipoprotein A-II in mouse tissues: possible contribution to mouse senile amyloidosis. J. Histochem. Cytochem. 2001, 49:739-748. 10.1177/002215540104900607.
11. Rankel R.M., Capone R. Xanthelasmas and xanthomas-cutaneous clues to systemic lipid disorders. Clin. Eye Vis. Care 1995, 7:117-128.
12. Zak A., Zeman M., Slaby A., Vecka M. Xanthomas: clinical and pathophysiological relations. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Republ. 2014, 158:181-188. 10.5507/bp.2014.016.
13. Schaefer E.J., Santos R.D., Asztalos B.F. Marked HDL deficiency and premature coronary heart disease. Curr. Opin. Lipidol. 2010, 21:289-297. 10.1097/MOL.0b013e32833c1ef6.
14. Fisher E.A., Feig J.E., Hewing B., Hazen S.L., Smith J.D. High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2813-2820. 10.1161/ATVBAHA.112.300133.
15. Zabalawi M., Bhat S., Loughlin T., Thomas M.J., Alexander E., Cline M., et al. Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. Am. J. Pathol. 2003, 163:1201-1213. 10.1016/S0002-9440(10)63480-3.
16. Chiesa G., Parolini C., Canavesi M., Colombo N., Sirtori C.R., Fumagalli R., et al. Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice. Arterioscler. Thromb. Vasc. Biol. 1998, 18:1417-1423. 10.1161/01.ATV.18.9.1417.
17. Mahley R.W., Huang Y., Weisgraber K.H. Putting cholesterol in its place: apoE and reverse cholesterol transport. J. Clin. Investig. 2006, 116:1226-1229. 10.1172/JCI28632.
18. Williamson R., Lee D., Hagaman J., Maeda N. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl. Acad. Sci. USA 1992, 89:7134-7138.
19. Marchesi M., Parolini C., Caligari S., Gilio D., Manzini S., Busnelli M., et al. Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL. Br. J. Pharmacol. 2011, 164:1460-1468. 10.1111/j.1476-5381.2011.01429.x.
20. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226:497-509.
21. Parolini C., Chiesa G., Zhu Y., Forte T., Caligari S., Gianazza E., Sacco M.G., Sirtori C.R., Rubin E.M. Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion. J. Biol. Chem. 2003, 278:4740-4746.
22. Cookson F.B. The origin of foam cells in atherosclerosis. Br J. Exp. Pathol. 1971, 52:62-69.
23. Feingold K.R., Elias P.M., Mao-Qiang M., Fartasch M., Zhang S.H., Maeda N. Apolipoprotein E deficiency leads to cutaneous foam cell formation in mice. J. Investig. Dermatol. 1995, 104:246-250.
24. Accad M., Smith S.J., Newland D.L., Sanan D.A., King L.E., Linton M.F., et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J. Clin. Investig. 2000, 105:711-719. 10.1172/JCI9021.
25. Aiello R.J., Brees D., Bourassa P.A., Royer L., Lindsey S., Coskran T., et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler. Thromb. Vasc. Biol. 2002, 22:630-637. 10.1161/01.ATV.0000014804.35824.DA.
26. Zabalawi M., Bharadwaj M., Horton H., Cline M., Willingham M., Thomas M.J., et al. Inflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance?. J. Lipid Res. 2007, 48:52-65. 10.1194/jlr.M600370-JLR200.
27. Wilhelm A.J., Zabalawi M., Owen J.S., Shah D., Grayson J.M., Major A.S., et al. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J. Biol. Chem. 2010, 285:36158-36169. 10.1074/jbc.M110.134130.
28. Lindeskog G.R., Gustafson A., Enerbäck L. Serum lipoprotein deficiency in diffuse "normolipemic" plane xanthoma. Arch. Dermatol. 1972, 106:529-532.
29. Grebe A., Latz E. Cholesterol crystals and inflammation. Curr. Rheumatol. Rep. 2013, 15:313-320. 10.1007/s11926-012-0313-z.
30. Lewis G.F., Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 2005, 96:1221-1232. 10.1161/01.RES.0000170946.56981.5c.
31. Matsuura F., Wang N., Chen W., Jiang X.C., Tall A.R. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J. Clin. Investig. 2006, 116:1435-1442. 10.1172/JCI27602.
32. Mahley R.W., Innerarity T.L., Bersot T.P., Lipson A., Margolis S. Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol. Lancet 1987, 2:807-809.
33. Bocan T.M., Schifani T.A., Guyton J.R. Ultrastructure of the human aortic fibrolipid lesion. Formation of the atherosclerotic lipid-rich core. Am. J. Pathol. 1986, 123:413-424.
34. Rajamäki K., Lappalainen J., Oörni K., Välimäki E., Matikainen S., Kovanen P.T., et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 2010, 5:e11765. 10.1371/journal.pone.0011765.